Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

62.48
Delayed Data
As of 2:00pm ET
 -0.69 / -1.09%
Today’s Change
26.80
Today|||52-Week Range
70.92
+38.46%
Year-to-Date
Regeneron/Sanofi Present Positive Phase III Praluent Data
10:05am / Zacks.com - Paid Partner Content
Amgen Gets CRL for Secondary Hyperparathyroidism Drug
Aug 25 / Zacks.com - Paid Partner Content
Abbott Labs Sued by Alere over Pending $5.8B Acquisition
9:19am / Zacks.com - Paid Partner Content
Mylan (MYL) Obtains Favorable USPTO Ruling for Copaxone
Aug 25 / Zacks.com - Paid Partner Content
Roche Gets FDA Nod for Emergency Use of Zika Virus Test
9:19am / Zacks.com - Paid Partner Content
Kindred Biosciences (KIN) Jumps: Stock Moves 5.7% Higher
Aug 25 / Zacks.com - Paid Partner Content
Mallinckrodt DMD Drug Gets Fast Track Status in the U.S.
Aug 26 / Zacks.com - Paid Partner Content
Urban Outfitters, Fogo de Chao, Oclaro, ANI Pharmaceuticals and FormFactor highlighte...
Aug 24 / Zacks.com - Paid Partner Content
Vanda Stock Up on Favorable U.S. Court Ruling for Fanapt
Aug 26 / Zacks.com - Paid Partner Content
Mylan (MYL) Draws Flak for Over Pricing EpiPen, Stock Down
Aug 24 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close63.17
Today’s open63.20
Day’s range61.20 - 63.23
Volume109,818
Average volume (3 months)225,793
Market cap$727.3M
Dividend yield--
Data as of 2:00pm ET, 08/29/2016

Growth & Valuation

Earnings growth (last year)-49.03%
Earnings growth (this year)+51.29%
Earnings growth (next 5 years)+15.40%
Revenue growth (last year)+36.36%
P/E ratio73.5
Price/Sales6.83
Price/Book4.54

Competitors

 Today’s
change
Today’s
% change
NTLAIntellia Therapeutic...-1.06-5.06%
BPMCBlueprint Medicines ...+0.28+1.00%
EDITEditas Medicine Inc-0.87-4.75%
NKNantKwest Inc+0.24+3.03%
Data as of 2:15pm ET, 08/29/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)$1.09
Annual revenue (last year)$76.3M
Annual profit (last year)$15.3M
Net profit margin20.03%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur S. Przybyl
Vice President-
Operations
James G. Marken
Corporate headquarters
Baudette, Minnesota

Forecasts

Partner Offers

Search for Jobs